Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Reovirus as a novel oncolytic agent
Kara L. Norman, Patrick W.K. Lee
Kara L. Norman, Patrick W.K. Lee
Published April 15, 2000
Citation Information: J Clin Invest. 2000;105(8):1035-1038. https://doi.org/10.1172/JCI9871.
View: Text | PDF
Perspective

Reovirus as a novel oncolytic agent

  • Text
  • PDF
Abstract

Authors

Kara L. Norman, Patrick W.K. Lee

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Usurpation of the Ras signaling pathway by reovirus. In untransformed, r...
Usurpation of the Ras signaling pathway by reovirus. In untransformed, reovirus-resistant cells, double-stranded RNA structures in reovirus transcripts activate PKR, which subsequently phosphorylates eIF-2α, inhibiting translation initiation of viral genes. In cells with an activated Ras signaling pathway, however, PKR phosphorylation in response to viral transcripts is inhibited and viral translation proceeds unimpeded.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts